The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acoustic-electric stimulation will be provided by the Nucleus® Hybrid L24 cochlear implant system.
Participants eighteen years of age or older who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss.
If you agree to be in the study, you will be asked to complete a number of preoperative (before surgery) evaluations, and undergo cochlear implant surgery. Participants may require one or more medical appointments during their recovery from surgery and will attend up to 6 postoperative (after surgery) study-related appointments over a 1-year period and then semi-annually until the Sponsor closes the study.
Participants will be enrolled in this study for approximately 2 to 3 years, though the majority of the postoperative evaluations will take place in the initial 12 months following surgery.
Last updated: 12/05/2012